1428621-79-7

Basic information

• Product Name: methyl 2-(2-((4-methylbenzoyl)imino)-6-(2-morpholinoethoxy)benzo[d]thiazol-3(2H)-yl)butanoate
• Synonyms: methyl 2-(2-((4-methylbenzoyl)imino)-6-(2-morpholinoethoxy)benzo[d]thiazol-3(2H)-yl)butanoate
• CAS NO: 1428621-79-7
• Molecular Weight: 497.615
• Mol File: 1428621-79-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl 2-(2-((4-methylbenzoyl)imino)-6-(2-morpholinoethoxy)benzo[d]thiazol-3(2H)-yl)butanoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-(2-((4-methylbenzoyl)imino)-6-(2-morpholinoethoxy)benzo[d]thiazol-3(2H)-yl)butanoate(1428621-79-7)
• EPA Substance Registry System: methyl 2-(2-((4-methylbenzoyl)imino)-6-(2-morpholinoethoxy)benzo[d]thiazol-3(2H)-yl)butanoate(1428621-79-7)

Safety Data

• Hazardous Substances Data: 1428621-79-7(Hazardous Substances Data)

Upstream product

• 1747-60-0 6-methoxybenzothiazol-2-ylamine 
• 26278-79-5 2-amino-6-hydroxybenzothiazole 
• 1428621-72-0 2-((4-methylbenzoyl)imino)-2,3-dihydrobenzo[d]thiazol-6-yl 4-methylbenzoate 
• 1428621-73-1 N-(6-hydroxybenzo[d]thiazol-2(3H)-ylidene)-4-methylbenzamide 
• 1428621-74-2 N-(6-((tert-butyldimethylsilyl)oxy)benzo[d]thiazol-2(3H)-ylidene)-4-methylbenzamide 
• 1428621-75-3 methyl 2-(6-((tert-butyldimethylsilyl)oxy)-2-((4-methylbenzoyl)imino)benzo[d]thiazol-3(2H)-yl)butanoate 
• 622-40-2 2-(morpholin-4-yl)ethanol 
• 1428621-76-4 methyl 2-(6-hydroxy-2-((4-methylbenzoyl)imino)benzo[d]thiazol-3(2H)-yl)butanoate 

Downstream Products

• 1428621-78-6 2-(2-((4-methylbenzoyl)imino)-6-(2-morpholinoethoxy)benzo[d]thiazol-3(2H)-yl)butanoic acid 

Relevant articles and documents

PHENYLIMIDE-CONTAINING BENZOTHIAZOLE DERIVATIVE OF ITS SALT AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Provided is a phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the phenylimide-containing benzothiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.